new glp-1 drugs Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More How GLP-1 medications are transforming
Description
In 2022, some of the top-selling drugs in this category were Novos Ozempic (US$ 8.7 billion), Lilly and partner Dainippon Sumitomos Trulicity (US$ 7.7 billion), Novos Victoza (US$ 1.8 billion), and Rybelsus (US$ 1.6 billion)
There are some risks associated with taking GLP-1 agonists
only Q&A sessions are restricted to paying subscribers
There are also differences in how these medications work and their effectiveness
Special Populations and Considerations Certain subgroups of adolescents may derive particular benefit from GLP-1 RA therapy or require special consideration
Ferdinand KC, Mahata I
